Curanex Pharmaceuticals Inc CURX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.70
- Day Range
- $4.60–4.70
- 52-Week Range
- $0.00–13.33
- Bid/Ask
- $4.50 / $6.66
- Shares Outstanding
- 1.57M
- Market Cap
- $7.37M
- Volume/Avg
- 1,330 / 21,329
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 6
Valuation
Metric | CURX |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.39 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | CURX |
|---|---|
Quick Ratio | 28.17 |
Current Ratio | 45.95 |
Interest Coverage | −2,558.50 |
Quick Ratio
CURX
Profitability
Metric | CURX |
|---|---|
Return on Assets (Normalized) | −129.78% |
Return on Equity (Normalized) | −135.31% |
Return on Invested Capital (Normalized) | −130.30% |
Return on Assets
CURX
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|s^GDJsG | LOCK|Jy>> | $136B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|Z$$<<mk | LOCK|vs#QQ | $98B | |||
| Moderna Inc MRNA | LOCK|BH!X&J | LOCK|WP | $80B | |||
| argenx SE ADR ARGX | LOCK|rZ<$&P# | LOCK|?p | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|mS%<?j | LOCK|^$ | $47B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|gLHV^w? | LOCK|xhy%$ | $31B | |||
| Incyte Corp INCY | LOCK|R%dFZZv | LOCK|wdj | $24B | |||
| BioNTech SE ADR BNTX | LOCK|j&sLNk | LOCK|DGq | $21B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|m@#k$&& | LOCK|&hhN | $20B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|%G&^R< | LOCK|xw | $16B |